Needles, pens and pressure: The GLP-1 challenge As GLP-1 therapies transform diabetes and obesity care, demand for prefilled pens and injectors is soaring
CLINICAL TRIAL EVIDENCE FOR DUAL GLP-1/GLUCAGON RAs AND TRIPLE AGONISTS IN MASH Survodutide Survodutide, a weekly dual GLP-1/GCG agonist, was assessed in a phase 2 dose-finding trial (NCT04771273) including 293 individuals with histologically confirmed MASH and fibrosis stages F1-F3 [46]
However, further research is needed to find solutions to questions such as, what mechanisms regulate shifts between metabolism
Lastly, the systemic effects of GLP-1RAs, such as body weight loss [103] and potential reduction in muscle mass [104], pose significant challenges for elderly individuals with neurodegenerative diseases
However, it can affect the liver if taken in high doses, so its essential to avoid taking other medications containing acetaminophen while using Nyquil
Because GLP-1 drugs slow stomach emptying, some doctors recommend temporarily stopping medications like Ozempic, Wegovy or Zepbound before surgery or procedures involving anesthesia
